US 6,982,096 B2
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Raymond P. Warrell, Jr., Westfield, N.J. (US); Pier Paolo Pandolfi, New York, N.Y. (US); and Janice L. Gabrilove, New York, N.Y. (US)
Assigned to Memorial Sloan-Kettering Cancer Center, New York, N.Y. (US)
Filed on Jan. 16, 2004, as Appl. No. 10/759,290.
Application 10/759290 is a continuation of application No. 10/425785, filed on Apr. 30, 2003, granted, now 6,723,351.
Application 10/425785 is a continuation of application No. 09/189965, filed on Nov. 10, 1998, granted, now 6,770,304.
Claims priority of provisional application 60/064655, filed on Nov. 10, 1997.
Prior Publication US 2004/0146573 A1, Jul. 29, 2004
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 33/36 (2006.01)
U.S. Cl. 424—623 6 Claims
 
1. A method for treating cancer, comprising determining the weight of a patient diagnosed with cancer, determining a therapeutically effective dosage amount of arsenic trioxide based upon said weight of said patient, and administering said therapeutically effective dosage amount to said patient.